AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 6,951.50
-155.00 (-2.18%)
Aug 31, 2026, 3:30 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 174.27 billion as of August 31, 2026. Its market cap has decreased by -17.70% in one year.
Market Cap
174.27B
Enterprise Value
170.90B
Revenue
24.32B
Ranking
n/a
PE Ratio
102.74
Stock Price
6,951.50
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 174.27B, an increase of 11,918.53%. That is a compound annual growth rate of 21.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 174.27B | -22.63% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 354.59B |
| Wockhardt | 321.26B |
| Piramal Pharma | 290.22B |
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |
| Alembic Pharmaceuticals | 159.89B |
| NATCO Pharma | 152.92B |